2nd Annual European Congress on Hematology™: Focus on Lymphoid Malignancies -- Call for Poster Abstracts!
The European Congress on Hematology™: Focus on Lymphoid Malignancies Program Chairs invite you to submit your abstracts for the 2nd Annual European Congress on Hematology™: Focus on Lymphoid Malignancies to be held 20 and 21 October 2017, at The Westin Paris-Vendôme in Paris, France.
Deadline for submission is 8 September 2017, at 11:59 AM US EDT (5:59 CEDT).
All poster abstracts must be submitted electronically through the congress' online abstract submission system.
Your abstract should be a short description of your work focused on Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma, containing all the elements necessary to define your goals and results to the reader. Authors will be required to disclose all financial relationships through the online system, helping to ensure quality and unbiased presentations. The formal poster session is not designated for credit.
Share your research or best practices with your peers. Categories of submission include:
Note: Trial in progress and encore abstracts are accepted.
The Program chairs will evaluate the scientific quality of the submitted abstracts on the basis of the following criteria: novelty of the research, significance of the findings, and clarity. Incomplete abstracts will not be reviewed.
Notification of acceptance, or regret, will be delivered via e-mail to the presenter(s) of each poster abstract, by mid-September. Please note that an author is required to be present during the poster session.
If accepted for presentation, abstracts and posters will be available for viewing online on the 2017 congress website during and after the conference. The posters will be displayed for the length of the conference. The presentation at the congress should reflect the submitted abstract title, authorship, and content of the presentation at the congress must match the submitted abstract.
All presenters must register to attend the 2nd Annual European Congress on Hematology™: Focus on Lymphoid Malignancies. Please click here to register.
Components of the Abstract Body-Limit: 2500 Characters (1 table allowed)
Please submit any questions pertaining to abstract submissions to firstname.lastname@example.org using the subject line "European Congress on Hematology™ Abstract QUESTION."
Author Consent and Waiver of Claims
Note: The hotel is expected to sell out and likely to do so before the discounted cut-off date of the 1 October 2017. Reservations may be made online here.
Oncology Briefings™: Updates in Therapeutic Options and Approaches for Tenosynovial Giant Cell Tumors
Apr 28, 2018
April 28, 2018
New York, NY